Emergency Plug-assisted Retrograde Transvenous Obliteration Using an Optimo 9-Fr Balloon Guiding Catheter: A Case Report Authors: Yohei Takeshita, Junji Moriya, Yo Matsui, Shintaro Chiba Published: 2025 ABSTRACT Gastric variceal rupture requires rapid hemostasis. When an abdominal balloon catheter is unavailable, alternatives are needed. We report emergency plug-assisted retrograde transvenous obliteration performed with a 9-Fr Optimo balloon-guiding catheter in a 59-year-old man with alcoholic cirrhosis and fundal gastric varices. Under balloon occlusion, balloon-occluded retrograde transvenous venography delineated the variceal complex. A 10-mm Amplatzer Vascular Plug II was deployed via the Optimo, followed by stepwise injection of gelatin sponge particles through a high-flow microcatheter. Complete occlusion was achieved without complications. Follow-up computed tomography and endoscopy confirmed improvement. The Optimo enabled single-system balloon-occluded retrograde transvenous venography, plug deployment, and embolic delivery through one venous access, offering a practical option for urgent hemostasis when inventory constraints exist, provided that preprocedural computed tomography confirms device compatibility. Introduction Gastric variceal rupture carries a high risk of exsanguination, necessitating a rapid and reproducible hemostatic strategy. Balloon-occluded retrograde transvenous obliteration (BRTO) is a long-established technique with well-described concepts, procedural standards, and outcomes [1, 2]. Sclerosants such as ethanolamine oleate and polidocanol foam are widely used, and comparative data are available [3]. Plug-assisted retrograde transvenous obliteration (PARTO) modifies the outflow-occlusion step by combining a vascular plug with adjunct embolic material; since the initial report, prospective multicenter and emergency-setting data have supported its utility [4, 5]. Reviews have synthesized modified BRTO methods (PARTO/coil-assisted retrograde transvenous obliteration [CARTO]) and their indications [6]. Here, we describe an emergency PARTO performed with a 9-Fr Optimo balloon-guiding catheter in the absence of an abdominal balloon catheter and discuss practical advantages of this implementation. Case Report A 59-year-old man with untreated alcoholic cirrhosis (Child-Pugh score, 5) was transported for hematemesis. On arrival, his blood pressure was 93/67 mmHg and pulse 106 beats/min; conjunctival pallor and scleral icterus were present. Hemoglobin was 12.5 g/dL. Endoscopy showed esophageal varices (Li, F1, Cb, RC−) and large fundal gastric varices (Lg-f, F3, E−), according to the Japanese Society for Portal Hypertension endoscopic classification system [7], with transient active bleeding that ceased spontaneously; no endoscopic therapy was performed (Figure 1). Contrast-enhanced CT demonstrated markedly tortuous fundal varices without definite extravasation (Figure 2). Multiplanar reconstruction estimated the gastrorenal (GR) shunt diameter at approximately 7 mm (Figure 3). Baseline endoscopy at presentation. Fundal gastric varix with active bleeding (arrow). Preprocedural contrast-enhanced CT. Axial image showing large fundal varices (arrow). Preprocedural contrast-enhanced CT. Coronal MPR highlighting the gastrorenal (GR) shunt; multiplanar measurements estimated the GR shunt diameter at 7 mm, supporting selection of a 10-mm Amplatzer Vascular Plug II. Procedure Because abdominal balloon catheters (e.g., a Celiac Artery Narrowing and Distal Inflow SuppressionⓇ balloon occlusion catheter, Medikit, Tokyo, Japan, and a Selective Contrast InjectionⓇ MP Catheter II, Terumo Clinical Supply, Gifu, Japan) were not in stock, an OptimoⓇ EPD 9-Fr balloon-guiding catheter (Tokai Medical Products, Aichi, Japan) was selected. A 9-Fr long sheath was placed via the right femoral vein, and a Countdown JB2 catheter (6 Fr, 125-cm usable length; Medikit) was used to advance the Optimo into the GR shunt. Under balloon occlusion, balloon-occluded retrograde transvenous venography (BRTV) delineated the left inferior phrenic vein and the entire fundal variceal complex (Hirota grade 2), classified according to the Japanese Society of Portal Hypertension BRTV classification system (Figure 4) [8]. A Carry Leon High Flow microcatheter (2.9 Fr, 120 cm; UTM Co., Ltd., Nagoya, Japan) was positioned distally in the shunt, and a 10-mm Amplatzer™ Vascular Plug II (Abbott Vascular, Santa Clara, CA, USA) was deployed. After confirming the absence of renal-side reflux by contrast injection through the Optimo, gelatin sponge particles (SerescueⓇ, Nihon Kayaku Co., Tokyo, Japan) were injected in small, stepwise aliquots until uniform stagnation was achieved throughout the left inferior phrenic vein and the entire gastric variceal complex. This was followed by plug detachment and system removal (Figure 5). The puncture site was managed with manual compression. Total fluoroscopy time was 40 minutes 33 seconds, and total procedure time was 105 minutes. Angiography under Optimo 9-Fr balloon occlusion. BRTV delineating the entire fundal variceal complex (arrow) and the inferior phrenic vein (arrowhead) (Hirota grade 2). BRTV: balloon-occluded retrograde transvenous venography Deployment of a 10-mm AVP II (arrowhead) across the GR shunt, followed by stepwise injection of 3-4-mm gelatin sponge cubes via a high-flow microcatheter (arrow). GR: gastrorenal Results The procedure was completed without complications. Postprocedural CT demonstrated loss of enhancement of the gastric varices, indicating complete occlusion (Figure 6). Follow-up endoscopy showed shrinkage of the gastric varices. The esophageal varices exhibited mild worsening, but there was no rebleeding or other adverse event, and the patient was discharged in stable condition. Follow-up contrast-enhanced CT at 2 weeks. Disappearance of enhancement of the fundal varices, consistent with complete occlusion (arrow). Discussion BRTO remains an effective hemostatic option but requires sclerosants and prolonged balloon occlusion, and hematuria and renal events have been reported [1-3]. By eliminating renal-side reflux with a plug prior to embolic delivery, PARTO can shorten procedure time and mitigate drug-related adverse effects. Initial reports, a prospective multicenter study, and comparative cohorts have shown high technical success and acceptable clinical outcomes [4, 5]; additional data now support long-term outcomes for refractory hepatic encephalopathy and the effectiveness of emergency PARTO for ruptured varices [4, 9, 10]. An important practical reason for selecting the 9-Fr Optimo in this case was the ability to complete key steps within a single system. Although designed for neurovascular use, the Optimo's braided shaft offers proximal support and torque transmission, while the soft distal segment with a compliant balloon permits low-pressure, partial inflation as a temporary anchor at the shunt neck to minimize kickback during selection and microcatheter advancement. Using a 6-Fr JB2 catheter with a hydrophilic 0.035-inch guidewire as an inner dilator enabled smooth traversal of the frequently acute takeoff between the left renal vein and the GR shunt, consistent with the reported support and track performance of balloon-guide catheters [11]. In cases in which the angle between the inferior vena cava and the left renal vein, or between the left renal vein and the GR shunt, is steep, an internal jugular vein approach may be more appropriate. Once stably positioned at the shunt ostium, the large-bore lumen (compatible devices up to 0.088 inch) provided a reliable platform for coaxial delivery of the high-flow microcatheter and the Amplatzer Vascular Plug II (AVP II), facilitating continuous BRTV, controlled plug deployment, and subsequent embolic injection without exchanges. A procedural caveat concerns GR-shunt diameter and plug selection. In this patient, occlusion was achieved with a 10-mm AVP II. When GR shunts require AVP II devices ≥14 mm and at least an 8-Fr delivery system, simultaneous coaxial use of a high-flow microcatheter within the 9-Fr Optimo may be impractical; a separate access route for the microcatheter should then be planned. Preprocedural CT measurements are therefore recommended to confirm that occlusion is achievable with an AVP II ≤12 mm before adopting a single-system strategy. From a comparative standpoint, CARTO typically entails dense coil packing of the GR shunt followed by embolic infusion via a separate microcatheter; double-digit coil counts are not uncommon, which increases device cost and procedural steps and tends to prolong procedure time [5, 6]. By contrast, PARTO generally relies on a single plug plus adjunct embolic material, reducing device count and workflow complexity [4-6]. In our case, plug deployment reliably blocked renal-side reflux, enabling low-pressure, intermittent, stepwise injection to achieve uniform stagnation without additional devices. BRTO remains important, but its reliance on sclerosants and prolonged occlusion makes PARTO with a 9-Fr Optimo a rational choice in emergencies in terms of time efficiency, cost-effectiveness, and workflow [1-3]. Anatomically, afferent supply to fundal gastric varices commonly involves the left gastric, posterior gastric, and short gastric veins; BRTV-guided planning to anticipate embolic reach and manage reflux is important for complete occlusion. To our knowledge, a PubMed-based search did not identify prior case reports of PARTO performed with an Optimo balloon-guiding catheter. This single case demonstrates feasibility and handling advantages but is limited by potential variability in shunt morphology, device fit, and venous anatomy; structured endoscopic and imaging follow-up remains essential across PARTO, CARTO, and BRTO cohorts[4-6, 9, 10]. Conclusion In an emergency when an abdominal balloon catheter was unavailable, PARTO using a 9-Fr Optimo balloon-guiding catheter enabled BRTV and allowed final embolization within a single system, achieving complete occlusion without complications. This approach appears practical for urgent hemostasis, offering advantages in efficiency, cost, and implementation, provided that preprocedural imaging confirms device compatibility. Author Contributions Conceptualization: YT, JM, YM. Methodology: JM. Investigation (procedure performance): YT. Data curation (clinical/imaging): YT, JM. Writing - original draft: YT. Writing - review & editing: YT, JM, YM, SC. Supervision: JM. Project administration: JM. Guarantor of the article: YT. Meeting ICMJE authorship criteria, approving the final manuscript, and agreeing to be accountable for all aspects of the work: All authors Conflicts of Interest There are no conflicts of interest. Clinical Registration Number Not applicable (single-patient case report; no trial registration). Informed Consent Written informed consent was obtained from the patient for publication of this case report and images.